Európska únia - slovenčina - EMA (European Medicines Agency)

merck sharp & dohme b.v. - ertugliflozin l-pyroglutamic acid, metformin hydrochloride - diabetes mellitus, typ 2 - drugs used in diabetes, combinations of oral blood glucose lowering drugs - segluromet is indicated in adults aged 18 years and older with type 2 diabetes mellitus as an adjunct to diet and exercise to improve glycaemic control:in patients not adequately controlled on their maximally tolerated dose of metformin alonein patients on their maximally tolerated doses of metformin in addition to other medicinal products for the treatment of diabetesin patients already being treated with the combination of ertugliflozin and metformin as separate tablets.

Európska únia - slovenčina - EMA (European Medicines Agency)

accord healthcare s.l.u. - sitagliptin hydrochloride - diabetes mellitus, typ 2 - lieky používané pri cukrovke - for adult patients with type 2 diabetes mellitus, sitagliptin accord is indicated to improve glycaemic control:as monotherapy:- in patients inadequately controlled by diet and exercise alone and for whom metformin is inappropriate due to contraindications or intolerance. as dual oral therapy in combination with:- metformin when diet and exercise plus metformin alone do not provide adequate glycaemic control. - a sulphonylurea when diet and exercise plus maximal tolerated dose of a sulphonylurea alone do not provide adequate glycaemic control and when metformin is inappropriate due to contraindications or intolerance. - a peroxisome proliferator-activated receptor gamma (ppary) agonist (i. a thiazolidinedione) when use of a ppary agonist is appropriate and when diet and exercise plus the ppary agonist alone do not provide adequate glycaemic control. as triple oral therapy in combination with:- a sulphonylurea and metformin when diet and exercise plus dual therapy with these medicinal products do not provide adequate glycaemic control. - a ppary agonist and metformin when use of a ppary agonist is appropriate and when diet and exercise plus dual therapy with these medicinal products do not provide adequate glycaemic control. sitagliptin accord is also indicated as add-on to insulin (with or without metformin) when diet and exercise plus stable dose of insulin do not provide adequate glycaemic control.

Slovensko - slovenčina - ŠÚKL (Štátny ústav pre kontrolu liečiv)

as grindeks, lotyšsko - metformín a sitagliptín - 18 - antidiabetica (vrÁtane inzulÍnu)

Slovensko - slovenčina - ŠÚKL (Štátny ústav pre kontrolu liečiv)

as grindeks, lotyšsko - metformín a sitagliptín - 18 - antidiabetica (vrÁtane inzulÍnu)

Slovensko - slovenčina - ŠÚKL (Štátny ústav pre kontrolu liečiv)

reddy holding gmbh, nemecko - metformín a sitagliptín - 18 - antidiabetica (vrÁtane inzulÍnu)

Slovensko - slovenčina - ŠÚKL (Štátny ústav pre kontrolu liečiv)

reddy holding gmbh, nemecko - metformín a sitagliptín - 18 - antidiabetica (vrÁtane inzulÍnu)

Slovensko - slovenčina - ŠÚKL (Štátny ústav pre kontrolu liečiv)

stada arzneimittel ag, nemecko - metformín a sitagliptín - 18 - antidiabetica (vrÁtane inzulÍnu)

Slovensko - slovenčina - ŠÚKL (Štátny ústav pre kontrolu liečiv)

stada arzneimittel ag, nemecko - metformín a sitagliptín - 18 - antidiabetica (vrÁtane inzulÍnu)

Slovensko - slovenčina - ŠÚKL (Štátny ústav pre kontrolu liečiv)

krka, d.d., novo mesto, slovinsko - metformín a sitagliptín - 18 - antidiabetica (vrÁtane inzulÍnu)

Európska únia - slovenčina - EMA (European Medicines Agency)

boehringer ingelheim international gmbh - linagliptin, metformín - diabetes mellitus, typ 2 - lieky používané pri cukrovke - liečba dospelých pacientov s typu 2 diabetes mellitus:jentadueto je uvedené ako doplnok stravy a cvičenia na zlepšenie glykemický kontroly u dospelých pacientov nedostatočne kontrolované na ich maximálna tolerovaná dávka metformín sám, alebo tí, ktorí už liečená kombinácia linagliptin a metformínom. jentadueto je indikovaný v kombinácii s sulfonylmocoviny i. triple kombinovaná liečba) ako doplnok stravy a cvičenia dospelých pacientov nedostatočne kontrolované na ich maximálna tolerovaná dávka metformín a sulfonylmocoviny.